Schedule 13G: CVI Investments and Heights Capital Report 365,849 SSKN Shares

Rhea-AI Filing Summary

Strata Skin Sciences, Inc. Schedule 13G discloses that CVI Investments, Inc. and its investment manager Heights Capital Management, Inc. together report beneficial ownership of 365,849 shares, representing 6.9% of the outstanding common stock (based on 5,268,708 shares outstanding per the Company prospectus supplement). The filing shows no sole voting or dispositive power and records shared voting and dispositive power over all reported shares. Heights Capital is identified as investment manager and authorized agent for CVI Investments via a limited power of attorney.

Positive

• Transparent disclosure of a 6.9% position in Strata Skin Sciences with specific share and share-count basis
• Schedule 13G filing indicates passive intent rather than an acquisition to change control
• Identifies governance and reporting relationships by naming CVI Investments and Heights Capital and attaching a Limited Power of Attorney

Negative

• No sole voting or dispositive power reported, meaning the reporting persons do not control voting decisions for these shares
• Position size (6.9%) is material relative to outstanding shares but still below a controlling stake

Insights

Institutional Investor Relations Analyst

TL;DR: A disclosed 6.9% passive stake held via an investment vehicle with shared voting/dispositive authority.

The filing clearly reports a non-control position of 365,849 shares equal to 6.9% of the company, filed on Schedule 13G rather than 13D which signals a passive investor intent. The structure shows CVI Investments as the record owner and Heights Capital as the investment manager and authorized agent, with shared voting and dispositive power and no sole control. The disclosure includes the prospectus-derived share count used to calculate the percentage and references a Limited Power of Attorney and Joint Filing Agreement as exhibits.

Corporate Governance Specialist

TL;DR: Governance impact appears limited: shared authority and an explicit disclaimer of beneficial ownership beyond pecuniary interest.

The Schedule 13G includes certification that the shares were not acquired to influence control and contains explicit disclaimers that each reporting person disclaims beneficial ownership except for pecuniary interest. The absence of sole voting or dispositive power and the use of Schedule 13G support a characterization of the position as passive. Exhibits listed (Limited Power of Attorney and Joint Filing Agreement) document the reporting mechanics between manager and investor.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Strata Skin Sciences, Inc.

(Name of Issuer)

Common Stock, $0.001 par value per share

(Title of Class of Securities)

86272A305

(CUSIP Number)

09/02/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 86272A305

1

Names of Reporting Persons

CVI Investments, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 365,849.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 365,849.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

365,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.

SCHEDULE 13G

CUSIP No. 86272A305

1

Names of Reporting Persons

Heights Capital Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 365,849.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 365,849.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

365,849.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.9 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Strata Skin Sciences, Inc.
(b)	Address of issuer's principal executive offices: 5 Walnut Grove Drive, Suite 140, Horsham, PA 19044
Item 2.
(a)	Name of person filing: This statement is filed by the entities listed below, who are collectively referred to herein as "Reporting Persons," with respect to the shares of common stock of Strata Skin Sciences, Inc. (the "Company"), $0.001 par value per share (the "Shares"). (i) CVI Investments, Inc. (ii) Heights Capital Management, Inc.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of CVI Investments, Inc. is: P.O. Box 309GT Ugland House South Church Street George Town Grand Cayman KY1-1104 Cayman Islands The address of the principal business office of Heights Capital Management, Inc. is: 101 California Street, Suite 3250 San Francisco, California 94111
(c)	Citizenship: Citizenship is set forth in Row 4 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
(d)	Title of class of securities: Common Stock, $0.001 par value per share
(e)	CUSIP No.: 86272A305
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The information required by this Item 4(a) is set forth in Row 9 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. The Company's Prospectus Supplement (to Prospectus dated December 18, 2024, Registration No. 333-283418), filed on September 3, 2025, indicates there were 5,268,708 Shares outstanding as of the completion of the offering of the Shares referred to therein.
(b)	Percent of class: 6.9 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: The information required by this Item 4(c)(i) is set forth in Row 5 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
	(ii) Shared power to vote or to direct the vote: The information required by this Item 4(c)(ii) is set forth in Row 6 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. Heights Capital Management, Inc., which serves as the investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.
	(iii) Sole power to dispose or to direct the disposition of: The information required by this Item 4(c)(iii) is set forth in Row 7 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: The information required by this Item 4(c)(iv) is set forth in Row 8 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person. Heights Capital Management, Inc., which serves as the investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc. Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest therein.
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CVI Investments, Inc.

Signature:	/s/ Sarah Travis
Name/Title:	Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:	09/08/2025

Heights Capital Management, Inc.

Signature:	/s/ Sarah Travis
Name/Title:	Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:	09/08/2025

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which is attached as Exhibit I hereto.

Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION ________ ________ I Limited Power of Attorney II Joint Filing Agreement

FAQ

What stake in Strata Skin Sciences (SSKN) do CVI Investments and Heights Capital report?

They report beneficial ownership of 365,849 shares, representing 6.9% of the outstanding common stock based on the prospectus supplement share count.

Does the filing indicate the investors seek to change control of SSKN?

No. The filing is on Schedule 13G and contains a certification that the securities were not acquired to change or influence control.

Who holds voting and dispositive power over the reported shares?

The filing shows no sole voting or dispositive power; both voting and dispositive power are reported as shared (365,849 shares).

What entities filed this Schedule 13G for SSKN?

The filers are CVI Investments, Inc. (Cayman Islands) and Heights Capital Management, Inc. (Delaware), with Heights Capital serving as investment manager and authorized agent.

What documents are attached as exhibits to the filing?

The exhibit index lists a Limited Power of Attorney and a Joint Filing Agreement.